IP Library Granted Patent US 7,211,711
Granted Patent B2
US 7,211,711 · App. 10/137,036 · Granted May 1, 2007

Compositions and methods for the modification of gene expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,211,711
App. No.
10/137,036
Granted
May 1, 2007
Kind
B2
Abstract

Novel isolated plant polynucleotide promoter sequences are provided, together with genetic constructs comprising such polynucleotides. Methods for using such constructs in modulating the transcription of DNA sequences of interest are also disclosed, together with transgenic plants comprising such constructs.

Claims (23)

1. An isolated polynucleotide comprisinng SEQ ID NO: 88.

2. A genetic construct comprising the polynucleotide of claim 1 .

3. A genetic construct comprising, in the 5′-3′ direction:

(a) a promoter sequence,

(b) a DNA sequence of interest; and

(c) a gene termination sequence,

wherein the promoter sequence comprises the isolated polynucleotide of claim 1 .

4. The genetic construct of claim 3 , wherein the DNA sequence of interest comprises an open reading frame encoding a polypeptide of interest.

5. A transgenic cell comprising the genetic construct of claim 3 .

6. A plant comprising the transgenic cell of claim 1 , or a part or propagule or progeny thereof, wherein the part, propagule or progeny comprises the transgenic cell of claim 1 .

7. A method for modifying gene expression in a target plant comprising stably incorporating into the genome of the plant the genetic construct according to claim 3 , wherein the gene expression in said plant is modified.

8. A method for producing a plant having modified gene expression comprising:

(a) transforming a plant cell with a genetic construct to provide a transgenic cell,

wherein the genetic construct comprises:

(i) a promoter sequence comprising the polynucleotide of claim 1 ;

(ii) a DNA sequence of interest; and

(iii) a gene termination sequence;

(b) cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth; and

(c) regenerating a plant having modified genetic expression, wherein said plant comprises said genetic construct.

9. A method for modifying a phenotype of a target plant, comprising stably incorporating into the genome of the target plant a genetic construct comprising:

(a) the polynucleotide of claim 1 ;

(b) a DNA sequence of interest; and

(c) a gene termination sequence, wherein the phenotype of said plant is modified.

Assignments (5)
SECURITY INTEREST Recorded Sep 19, 2018
From: ARBORGEN INC.
To: SYNOVUS BANK
Reel/Frame 046914/0788 →
SECURITY INTEREST Recorded Mar 31, 2015
From: ARBORGEN INC.
To: NBSC, A DIVISION ON SYNOVUS BANK
Reel/Frame 035348/0921 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME PREVIOUSLY RECORDED ON REEL 031085 FRAME 0871. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT AND THE ASSIGNOR'S CORRECT NAME SHOULD BE ARBORGEN INC. INSTEAD OF ABORGEN INC. Recorded Aug 28, 2013
From: ARBORGEN INC.
To: NBSC, A DIVISION ON SYNOVUS BANK
Reel/Frame 031098/0188 →
SECURITY AGREEMENT Recorded Aug 26, 2013
From: ABORGEN INC.
To: NBSC, A DIVISION OF SYNOVUS BANK
Reel/Frame 031085/0871 →
CHANGE OF NAME Recorded Aug 15, 2013
From: ARBORGEN, LLC
To: ARBORGEN INC.
Reel/Frame 031029/0795 →